Product Information
MYSOLINE 250 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $65.6886 per EA under NDC 66490069110. Its NADAC has been published 176 times since Jan 22, 2014.
The High Outlier badge above means this manufacturer's average price in the Primidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Bausch Health US LLCNDC
66490069110
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
1/1/2025
Active Ingredients
PRIMIDONEApproval Type
New Drug (NDA)
FDA Application
NDA009170On Market Since
6/24/2009
Pharmacological Classes
Price Statistics
The NADAC for MYSOLINE 250 MG TABLET has been published 176 times since Jan 22, 2014, and over the history we have for it it has risen 512.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $65.6886 per EA |
|---|---|
| All-time high | $65.6886 (Oct 1, 2025) |
| All-time low | $10.4212 (Feb 19, 2014) |
| 52-week high | $65.6886 |
| 52-week low | $65.6886 |
| Median price | $39.6845 |
| Average price | $41.4830 |
| Largest weekly change | +57.6% (Aug 21, 2024) |
| Weeks tracked | 176 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MYSOLINE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MYSOLINE 250 MG TABLET, manufactured by Bausch Health US LLC, is $65.6886 per EA (NDC 66490069110), effective Oct 1, 2025.
How has the price of MYSOLINE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for MYSOLINE 250 MG TABLET has risen 512.0%. It has been tracked across 176 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for MYSOLINE 250 MG TABLET?
Since Jan 22, 2014, the NADAC for MYSOLINE 250 MG TABLET has ranged from a low of $10.4212 (Feb 19, 2014) to a high of $65.6886 (Oct 1, 2025), with a median of $39.6845 per EA.
Are there cheaper alternatives to MYSOLINE 250 MG TABLET?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PRIMIDONE 250 MG TABLET, is $0.2102 per EA — about 100% below MYSOLINE 250 MG TABLET.
Who manufactures MYSOLINE 250 MG TABLET?
MYSOLINE 250 MG TABLET (NDC 66490069110) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification